Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study

被引:22
|
作者
Maraba, Noriah [1 ,2 ,9 ]
Hoffmann, Christopher J. [1 ,3 ]
Chihota, Violet N. [1 ,2 ]
Chang, Larry W. [3 ]
Ismail, Nazir [4 ]
Candy, Sue [4 ]
Madibogo, Edwin [5 ]
Katzwinkel, Marc [6 ]
Churchyard, Gavin J. [1 ,2 ,7 ,8 ]
McCarthy, Kerrigan [1 ,2 ,4 ]
机构
[1] Aurum Inst, Johannesburg, South Africa
[2] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] Natl Inst Communicable Dis, Johannesburg, South Africa
[5] City Johannesburg, Dept Hlth & Social Dev, Johannesburg, South Africa
[6] Mobenzi, Cape Town, South Africa
[7] South African Med Res Council Collaborating Ctr H, Adv Treatment & Care TB&HIV, Johannesburg, South Africa
[8] London Sch Trop & Hyg Med, London, England
[9] Fdn Innovat New Diagnost, Geneva, Switzerland
来源
PLOS ONE | 2018年 / 13卷 / 07期
基金
美国国家卫生研究院;
关键词
CARE;
D O I
10.1371/journal.pone.0199687
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Tuberculosis (TB) incidence in South Africa is among the highest globally. Initial loss to follow-up (ILFU), defined as not starting on TB treatment within 28 days of testing positive, is undermining control efforts. We assessed the feasibility, acceptability, and potential of a mHealth application to reduce ILFU. Methods An mHealth application was developed to capture patients TB investigation data, provide results and monitor treatment initiation. This was implemented in two primary health clinics (PHC) in inner-city Johannesburg. Feasibility was assessed by comparing documentation of personal details, specimen results for same individuals during implementation period (paper register and Mhealth application). Effectiveness was assessed by comparing proportion of patients with results within 48 hours, and proportion started on treatment within 28 days of testing TB positive during pre- implementation (paper register) and implementation (mHealth application) periods. In-depth interviews with patients and providers were conducted to assess acceptability of application. Results Pre-implementation, 457 patients were recorded in paper registers [195 (42.7%) male, median age 34 years (interquartile range IQR (28-40), 45 (10.5%) sputum Xpert positive]. During implementation, 319 patients were recorded in paper register and the mHealth application [131 (41.1%) male, median age 32 years (IQR 27-38), 33 (10.3%) sputum Xpert positive]. The proportion with complete personal details: [mHealth 95.0% versus paper register 94.0%, (p = 0.54)] and proportion with documented results: [mHealth 97.4% versus paper register 97.8%, (p = 0.79)] were not different in the two methods. The proportion of results available within 48 hours: [mHealth 96.8% versus paper register 68.6%), (p < 0.001)], and the proportion on treatment within 28 days [mHealth 28/33 (84.8%) versus paper register 30/44 (68.2%), (p = 0.08)] increased during implementation but was not statistically significant. In-depth interviews showed that providers easily integrated the mHealth application into routine TB investigation and patients positively received the delivery of results via text message. Time from sputum collection to TB treatment initiation decreased from 4 days (pre-implementation) to 3 days but was not statistically significant. Conclusions We demonstrated that implementation of the mHealth application was feasible, acceptable to health care providers and patients, and has potential to reduce the time to TB treatment initiation and ILFU in PHC settings.
引用
下载
收藏
页数:12
相关论文
共 50 条
  • [31] Identification of performance indicators for emergency centres in South Africa: Results of a Delphi study
    Maritz D.
    Hodkinson P.
    Wallis L.
    International Journal of Emergency Medicine, 2010, 3 (4) : 341 - 349
  • [32] Choice-Based Reminder Cues: Findings From an mHealth Study to Improve Tuberculosis (TB) Treatment Adherence Among the Urban Poor in India
    Das Gupta, Debasree
    Patel, Amit
    Saxena, Deepak
    Koizumi, Naoru
    Trivedi, Poonam
    Patel, Krupali
    Raval, Devang
    King, Andrew
    Chandler, Kerianne
    WORLD MEDICAL & HEALTH POLICY, 2020, 12 (02): : 163 - 181
  • [33] THE DESIGN OF A CASE REGISTER FOR TUBERCULOSIS - A PILOT-STUDY IN THE SOUTH-WESTERN CAPE
    DICK, J
    YOUNGLESON, SM
    SOUTH AFRICAN MEDICAL JOURNAL, 1994, 84 (09): : 621 - 623
  • [34] IS IT TINDZHAKA OR TUBERCULOSIS? A STUDY OF TRADITIONAL DIAGNOSIS AND TREATMENT AMONG HEALERS IN BUSHBUCKRIDGE, SOUTH AFRICA
    Audet, Carolyn M.
    Ngobeni, Sizzy
    Wagner, Ryan G.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 594 - 595
  • [35] Successful Integration of Tuberculosis and HIV Treatment in Rural South Africa: The Sizonq'oba Study
    Gandhi, Neel R.
    Moll, Anthony P.
    Lalloo, Umesh
    Pawinski, Robert
    Zeller, Kimberly
    Moodley, Pravi
    Meyer, Eugene
    Friedland, Gerald
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (01) : 37 - 43
  • [36] Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa
    Mohr, Erika
    Hughes, Jennifer
    Reuter, Anja
    Duran, Laura Trivino
    Ferlazzo, Gabriella
    Daniels, Johnny
    De Azevedo, Virginia
    Kock, Yulene
    Steele, Sarah Jane
    Shroufi, Amir
    Ade, Serge
    Alikhanova, Natavan
    Benedetti, Guido
    Edwards, Jeffrey
    Cox, Helen
    Furin, Jennifer
    Isaakidis, Petros
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (06)
  • [37] Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial
    Elizabeth Lutge
    Simon Lewin
    Jimmy Volmink
    Irwin Friedman
    Carl Lombard
    Trials, 14
  • [38] Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial
    Lutge, Elizabeth
    Lewin, Simon
    Volmink, Jimmy
    Friedman, Irwin
    Lombard, Carl
    TRIALS, 2013, 14
  • [39] Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study
    Finlay, Alyssa
    Lancaster, Joey
    Holtz, Timothy H.
    Weyer, Karin
    Miranda, Abe
    van der Walt, Martie
    BMC PUBLIC HEALTH, 2012, 12
  • [40] Early culture conversion and cure for extensively drug-resistant tuberculosis is possible with appropriate treatment: lessons learnt from a case study in South Africa
    Shean, Karen
    Siwendu, Sweetness
    van der Walt, Martie
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 40 : 92 - 94